Skip to content
Screener

DENTSPLY SIRONA XRAY Wellspect Healthcare — Adjusted selling expenses

Similar metrics at other companies

Hillman Solutions Corp. logo
HLMNCanada — Adjusted selling expense
$3.66M+14.3%
Huron Consulting Group logo
HURNHealthcare — Selling, general and administrative expenses
$10.09M-7.0%
Bioventus logo
BVSInternational Segment — Adjusted selling expense
$3.39M+5.3%
Bioventus logo
BVSU.S. Segment — Adjusted selling expense
$39.05M+4.5%
Primo Brands logo
PRMBReportable Segment — Selling expense, adjusted
$119.4M+1.9%
Cigna logo
CICigna Healthcare — Adjusted revenues
$11.73B+9.1%

Other financials

Income statement

See full
Revenue$898.0M-4.1%
Gross profit$493.0M+0.6%
Operating income$82.0M+164%
Net income$37.0M+182%
EPS (diluted)$0.18+182%

Balance sheet

See full
Cash & equivalents$239.0M-33.4%
Total debt$2.3B-7.3%
Total equity$1.4B-31.1%
Total assets$5.2B-14.3%

Cash flow

See full
Operating cash flow$99.0M+106%
CapEx$44.0M+37.5%
Free cash flow$55.0M+244%

Valuation

See full
Market cap$2.64B-3.2%
Enterprise value$4.71B-3.1%
P/S0.7×0.0×

Profitability

See full
Gross margin49.5%-2.2pp
Operating margin-8.5%-3.5pp
Net margin-15%-4.4pp
FCF margin3.9%+0.2pp

Returns & leverage

See full
Return on equity-33%-3.7pp
Debt / equity1.7×+0.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept xray:SellingExpenseAdjusted.

The source filing: DENTSPLY SIRONA’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000818479-26-000255
(in millions)Three Months Ended June 30, 2026 / Connected Technology SolutionsThree Months Ended June 30, 2026 / Essential Dental SolutionsThree Months Ended June 30, 2026 / Orthodontic and Implant SolutionsThree Months Ended June 30, 2026 / Wellspect HealthcareThree Months Ended June 30, 2026 / Total
Net sales$239$376$197$86$898
Adjusted cost of products sold (a)1481198636
Adjusted selling expenses (b)53725915
Adjusted general and administrative (“G&A”) expenses (b)2020188
Adjusted research and development (“R&D”) expenses (c)207133
Segment adjusted operating income$(2)$158$21$24$201
Reconciling items (income) expense:
Unallocated corporate costs (d)$68

Item 1 – Financial Statements

FAQ

What is DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses?
DENTSPLY SIRONA (XRAY) reported wellspect healthcare — adjusted selling expenses of $15M in Q2 2026.
How has DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses changed year-over-year?
DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses increased by 15.4% year-over-year, from $13M to $15M.
What is the long-term trend for DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses?
Over 3 years (2022 to 2025), DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses has grown at a 4.6% compound annual growth rate (CAGR), from $48M to $55M.
What does wellspect healthcare — adjusted selling expenses mean?
Captures the costs incurred by the Wellspect Healthcare segment for sales, marketing, and distribution activities to support product commercialization. This metric provides insight into the investment required to maintain or expand the segment's market share and customer base.

Ask your AI about DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude